Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

4 SC AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

4SC - CLARITY ON RESMINOSTAT STRATEGY

4SC has clarified and simplified its development strategy for resminostat in first-line liver cancer. Having previously consi...

08 Apr 2014 Edison Investment Research 6 $10.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

04 Apr 2014 GlobalData 47 $125.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

07 Mar 2014 GlobalData 47 $125.00

4SC - SECURING FINANCIAL FLEXIBILITY

A €15m convertible note agreement with Yorkville provides 4SC with financial flexibility in a pivotal year for the company. E...

14 Feb 2014 Edison Investment Research 4 $10.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

05 Feb 2014 GlobalData 45 $125.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

10 Jan 2014 GlobalData 47 $125.00

4SC AG (VSC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

4SC AG (VSC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary 4SC AG (4SC) discovers and develops targete...

26 Dec 2013 GlobalData 35 $250.00

4SC - UPCOMING CLINICAL MILESTONES

Lead programme resminostat progressed in Q313, with 4SC refining its Phase II/III plans in front-line HCC and Japanese partne...

14 Nov 2013 Edison Investment Research 4 $10.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

09 Nov 2013 GlobalData 47 $125.00